PMID- 12270665 OWN - NLM STAT- MEDLINE DCOM- 20021204 LR - 20190901 IS - 0166-0934 (Print) IS - 0166-0934 (Linking) VI - 105 IP - 2 DP - 2002 Sep TI - Characterisation of a human herpesvirus 6 variant A 'amplicon' and replication modulation by U94-Rep 'latency gene'. PG - 331-41 AB - The human herpesvirus 6 (HHV-6) variant A genome has conserved sequences which are signals for initiating lytic replication (origin, 'ori-lyt') and DNA packaging into the virion (pac2/1). Here these are functionally characterised and used to construct a gene-expression amplifiable-vector, an 'amplicon', with applications for gene delivery to lymphoid-myeloid cells or their progenitor stem cells. A minimal efficient ori-lyt for replication was identified which was enhanced in the presence of the imperfect direct repeated DNA domain (IDR). In A variant strains these are arranged as three adjacent repeats with the most divergence in IDR3. Addition of the pac2/1 sequences also enhanced detection of ori-lyt replication and conferred DNA packaging properties, thus, the amplicon could be packaged with 'helper' virus. An HHV-6 specific factor, which inhibits amplicon replication was identified by trans replication assays. This is the U94-Rep 'latency' gene product, which can modulate efficiency of such amplifiable vectors, based on the lytic origin. It could also affect maintenance of viral genomes or vectors during latency. FAU - Turner, Simon AU - Turner S AD - Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, University of London, Keppel St., London WC1E 7HT, UK. FAU - DiLuca, Dario AU - DiLuca D FAU - Gompels, Ursula AU - Gompels U LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Virol Methods JT - Journal of virological methods JID - 8005839 RN - 0 (DNA Primers) SB - IM MH - Base Sequence MH - DNA Primers MH - Gene Amplification MH - *Genetic Variation MH - Herpesvirus 6, Human/*classification/*genetics/isolation & purification MH - Humans MH - Jurkat Cells MH - Plasmids MH - Polymerase Chain Reaction/methods MH - Restriction Mapping/methods MH - T-Lymphocytes/virology MH - Virus Replication/*physiology EDAT- 2002/09/25 06:00 MHDA- 2002/12/05 04:00 CRDT- 2002/09/25 06:00 PHST- 2002/09/25 06:00 [pubmed] PHST- 2002/12/05 04:00 [medline] PHST- 2002/09/25 06:00 [entrez] AID - S0166093402001301 [pii] AID - 10.1016/s0166-0934(02)00130-1 [doi] PST - ppublish SO - J Virol Methods. 2002 Sep;105(2):331-41. doi: 10.1016/s0166-0934(02)00130-1.